Considering the rapid increase in the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD, previously known as nonalcoholic fatty liver disease (NAFLD)) in humans (32), this novel aspect of Bach2 function deserves further attention. The gene discussed is BACH2; the disease is metabolic dysfunction-associated steatotic liver disease.